{"id":323626,"date":"2020-06-04T02:46:01","date_gmt":"2020-06-04T02:46:01","guid":{"rendered":"http:\/\/tehelka.com\/?p=323626"},"modified":"2020-06-04T02:46:01","modified_gmt":"2020-06-04T02:46:01","slug":"anti-malarial-drug-hydroxychloroquine-covid-19-trials-to-resume-says-who","status":"publish","type":"post","link":"https:\/\/tehelka.com\/anti-malarial-drug-hydroxychloroquine-covid-19-trials-to-resume-says-who\/","title":{"rendered":"Anti-malarial Drug Hydroxychloroquine Covid-19 trials to resume, says WHO"},"content":{"rendered":"<figure id=\"attachment_321930\" aria-describedby=\"caption-attachment-321930\" style=\"width: 478px\" class=\"wp-caption aligncenter\"><img decoding=\"async\" loading=\"lazy\" class=\"size-full wp-image-321930\" src=\"http:\/\/tehelka.com\/wp-content\/uploads\/2020\/04\/medicine-1.jpg\" alt=\"\" width=\"478\" height=\"427\" srcset=\"https:\/\/tehelka.com\/media\/2020\/04\/medicine-1.jpg 478w, https:\/\/tehelka.com\/media\/2020\/04\/medicine-1-300x268.jpg 300w, https:\/\/tehelka.com\/media\/2020\/04\/medicine-1-470x420.jpg 470w\" sizes=\"(max-width: 478px) 100vw, 478px\" \/><figcaption id=\"caption-attachment-321930\" class=\"wp-caption-text\">Representational Image<\/figcaption><\/figure>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">The World Health Organization (WHO) on Wednesday announced that it will resume the clinical trial of anti-malaria drug hydroxychloroquine for treatment of covid-19, a week after it suspended the trial pending review of its effectiveness.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">\u201cOn the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol. The Executive Group received this recommendation and endorsed the continuation of all arms of the Solidarity Trial, including hydroxychloroquine,\u201d WHO Director Tedros Adhanom Ghebreyesus said\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">\u201cLast week the Executive Group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug,\u201d the WHO director said.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">\u201cThis decision was taken as a precaution while the safety data were reviewed,\u201d he said.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">\u201cThe Data Safety and Monitoring Committee of the Solidarity Trial has been reviewing the data,\u201d Ghebreyesus said.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">He further said, \u201cThe Data Safety and Monitoring Committee will continue to closely monitor the safety of all therapeutics being tested in the Solidarity Trial.\u201d<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">US President Donald Trump have backed the drug for coronavirus prevention and treatment.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-family: 'times new roman', times, serif; font-size: 14pt;\">On May 25, WHO said it had temporary \u2018paused\u2019 the clinical trials of hydroxychloroquine in COVID-19 patients citing safety reasons.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The World Health Organization (WHO) on Wednesday announced that it will resume the clinical trial of anti-malaria drug hydroxychloroquine for treatment of covid-19, a week after it suspended the trial pending review of its effectiveness. \u201cOn the basis of the available mortality data, the members of the committee recommended that there are no reasons to [&hellip;]<\/p>\n","protected":false},"author":59,"featured_media":321930,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[53],"tags":[12750,13066,13060],"_links":{"self":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/323626"}],"collection":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/comments?post=323626"}],"version-history":[{"count":1,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/323626\/revisions"}],"predecessor-version":[{"id":323627,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/posts\/323626\/revisions\/323627"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/media\/321930"}],"wp:attachment":[{"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/media?parent=323626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/categories?post=323626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tehelka.com\/rest-api\/wp\/v2\/tags?post=323626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}